LT2874657T - Chimeriniai baltymai hpv/cyaa pagrindu, ir jų panaudojimas imuninio atsako prieš hpv infekciją ir hpv sukeltus sutrikimus sužadinimu - Google Patents

Chimeriniai baltymai hpv/cyaa pagrindu, ir jų panaudojimas imuninio atsako prieš hpv infekciją ir hpv sukeltus sutrikimus sužadinimu

Info

Publication number
LT2874657T
LT2874657T LTEP13739725.3T LT13739725T LT2874657T LT 2874657 T LT2874657 T LT 2874657T LT 13739725 T LT13739725 T LT 13739725T LT 2874657 T LT2874657 T LT 2874657T
Authority
LT
Lithuania
Prior art keywords
hpv
cyaa
induction
immune responses
chimeric proteins
Prior art date
Application number
LTEP13739725.3T
Other languages
English (en)
Lithuanian (lt)
Inventor
Yolande Misseri
Philippe Bridonneau
Anne Goubier
Original Assignee
Genkyotex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genkyotex filed Critical Genkyotex
Publication of LT2874657T publication Critical patent/LT2874657T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y406/00—Phosphorus-oxygen lyases (4.6)
    • C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
    • C12Y406/01001—Aodenylate cyclase (4.6.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP13739725.3T 2012-07-23 2013-07-23 Chimeriniai baltymai hpv/cyaa pagrindu, ir jų panaudojimas imuninio atsako prieš hpv infekciją ir hpv sukeltus sutrikimus sužadinimu LT2874657T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12305898.4A EP2689786A1 (en) 2012-07-23 2012-07-23 HPV/CYAA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders
PCT/EP2013/065549 WO2014016312A1 (en) 2012-07-23 2013-07-23 Hpv/cyaa-based chimeric proteins and their uses in the induction of immune responses against hpv infection and hpv-induced disorders

Publications (1)

Publication Number Publication Date
LT2874657T true LT2874657T (lt) 2019-02-25

Family

ID=48832935

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13739725.3T LT2874657T (lt) 2012-07-23 2013-07-23 Chimeriniai baltymai hpv/cyaa pagrindu, ir jų panaudojimas imuninio atsako prieš hpv infekciją ir hpv sukeltus sutrikimus sužadinimu

Country Status (21)

Country Link
US (1) US9827302B2 (OSRAM)
EP (2) EP2689786A1 (OSRAM)
JP (1) JP6466328B2 (OSRAM)
KR (1) KR20150031487A (OSRAM)
CN (1) CN104736173B (OSRAM)
AU (1) AU2013295047B2 (OSRAM)
CA (1) CA2879999A1 (OSRAM)
DK (1) DK2874657T3 (OSRAM)
ES (1) ES2712647T3 (OSRAM)
HR (1) HRP20190108T1 (OSRAM)
HU (1) HUE042808T2 (OSRAM)
LT (1) LT2874657T (OSRAM)
MX (1) MX2015001021A (OSRAM)
PL (1) PL2874657T3 (OSRAM)
PT (1) PT2874657T (OSRAM)
RS (1) RS58313B1 (OSRAM)
RU (1) RU2015100212A (OSRAM)
SI (1) SI2874657T1 (OSRAM)
SM (1) SMT201900057T1 (OSRAM)
TR (1) TR201900695T4 (OSRAM)
WO (1) WO2014016312A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2690172A1 (en) * 2012-07-23 2014-01-29 Genticel CYAA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses
EP3037103A1 (en) 2014-12-23 2016-06-29 Genticel Immunotherapeutic vaccine comprising E7 proteins of HPV16 and HPV18 fused with CyaA, for use in subjects infected with HPV
EP3323424A1 (en) * 2016-11-17 2018-05-23 Cyanimal IP Cyaa polypeptides as immune enhancer
JP2021534761A (ja) * 2018-08-23 2021-12-16 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性タンパク質および組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01209817A (ja) 1988-02-17 1989-08-23 Yamaha Corp 浮動少数点形ディジタル・アナログ変換器
DE60042687D1 (de) 2000-09-15 2009-09-17 Pasteur Institut Proteinhaltigen Vektoren zur Einführung von Moleküle in CD11b exprimirende Zellen
EP1489092A1 (en) 2003-06-18 2004-12-22 Institut Pasteur Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
DK1576967T3 (da) * 2004-03-18 2008-01-21 Pasteur Institut Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse
CN103983634A (zh) 2008-07-22 2014-08-13 普罗美加公司 基于adp检测的发光磷酸转移酶或atp水解酶测定
EP2478915A1 (en) * 2011-01-24 2012-07-25 Genticel CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses

Also Published As

Publication number Publication date
WO2014016312A1 (en) 2014-01-30
KR20150031487A (ko) 2015-03-24
AU2013295047A1 (en) 2015-02-05
US20150250867A1 (en) 2015-09-10
TR201900695T4 (en) 2019-03-21
HK1208822A1 (en) 2016-03-18
US9827302B2 (en) 2017-11-28
SI2874657T1 (sl) 2019-03-29
EP2874657B1 (en) 2018-10-17
AU2013295047B2 (en) 2018-02-22
CN104736173A (zh) 2015-06-24
DK2874657T3 (en) 2019-02-11
RS58313B1 (sr) 2019-03-29
HRP20190108T1 (hr) 2019-03-22
CA2879999A1 (en) 2014-01-30
HUE042808T2 (hu) 2019-07-29
RU2015100212A (ru) 2016-09-10
CN104736173B (zh) 2019-02-05
EP2874657A1 (en) 2015-05-27
JP6466328B2 (ja) 2019-02-13
PT2874657T (pt) 2019-02-18
ES2712647T3 (es) 2019-05-14
PL2874657T3 (pl) 2019-05-31
SMT201900057T1 (it) 2019-02-28
JP2015524420A (ja) 2015-08-24
MX2015001021A (es) 2015-08-05
EP2689786A1 (en) 2014-01-29

Similar Documents

Publication Publication Date Title
ZA201502603B (en) Enhancement of the immune response
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
IL234621A0 (en) Loaded dietary proteins and methods
IL236809A0 (en) Interleukin-10 fusion proteins and their use
PT3318268T (pt) Flagelina de roseburia e modulação imunitária
GB2526400B (en) Induction heating cooker
GB2489815B (en) Produced fluid heating and separation
EP2525817B8 (en) Vaccine vectors and methods of enhancing immune responses
GB2520887B (en) Induction heating cooker
SI2874657T1 (sl) Himerni proteini na osnovi-HPV/CYAA in njihove uporabe v indukciji imunskih odzivov proti infekciji HPV in HPV-induciranih motnjah
PL2873417T3 (pl) Induktor tolerancji immunologicznej
AU2014318672B2 (en) Recombinant microorganisms and methods of use thereof
EP2945464A4 (en) INDUCTION HEATING UNIT AND INDUCTION HEATING COOKER
GB201318220D0 (en) Battery powered food or beverage induction heater
PL2890253T3 (pl) Spożywczy koncentrat w postaci żelu oraz sposób jego wytwarzania
EP3018976A4 (en) Induction heating cooker
AU2012901301A0 (en) Treatment of inflammatory and immune disorders
IL233882A0 (en) bcl–2 antagonists and their uses in induction of apoptosis
HK1187834A (en) Cyaa-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses
IL220005A0 (en) Combination food cooler and heater